Cargando…

Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: A multicenter study

Four clinical isolates of imipenem-resistant Klebsiella pneumoniae were isolated from clinical patient specimens and from samples obtained from hygienic surveillance in our hospital. We examined their minimum inhibitory concentration (MIC) to various types of antibiotics, detected the carbapenemases...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, HUIHONG, YUEHUA, XUE, SHEN, WEIWEI, ZHOU, HUA, ZHOU, LIZHONG, LI, ZHAOYUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572730/ https://www.ncbi.nlm.nih.gov/pubmed/23128404 http://dx.doi.org/10.3892/mmr.2012.1155

Ejemplares similares

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility
por: Mashaly, Mervat El-Sayed, et al.
Publicado: (2021)

In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase
por: Wang, Chunlei, et al.
Publicado: (2021)

The First Case of Septicemia Caused by Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniae
por: Kayama, Shizuo, et al.
Publicado: (2013)

2181. Avibactam Prevents the in vitro Development of Imipenem Resistance in non-Carbapenemase-Producing Klebsiella pneumoniae
por: Quesille-Villalobos, Ana M, et al.
Publicado: (2023)

Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
por: Xiao, Shu-Zhen, et al.
Publicado: (2016)

First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling
por: Tian, Xuebin, et al.
Publicado: (2020)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

Machine learning model of imipenem‐resistant Klebsiella pneumoniae based on MALDI‐TOF‐MS platform: An observational study
por: Zeng, Yu, et al.
Publicado: (2023)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae
por: Ding, Li, et al.
Publicado: (2022)

Analysis of Capped Silver Nanoparticles Combined with Imipenem against Different Susceptibility Profiles of Klebsiella pneumoniae
por: Fontoura, Inglid, et al.
Publicado: (2023)

Epidemiological Study of Carbapenem-resistant Klebsiella Pneumoniae
por: Lin, Di, et al.
Publicado: (2018)

No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli
por: Yayan, Josef, et al.
Publicado: (2015)

Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
por: Hassuna, Noha Anwar, et al.
Publicado: (2020)

Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem‐resistant Klebsiella pneumoniae isolates
por: Park, Yumi, et al.
Publicado: (2020)

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
por: Zilberberg, Marya D, et al.
Publicado: (2010)

Epidemiological Characteristics and Formation Mechanisms of Multidrug-Resistant Hypervirulent Klebsiella pneumoniae
por: Tang, Miran, et al.
Publicado: (2020)

Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
por: Gaibani, Paolo, et al.
Publicado: (2022)

Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae
por: Lin, Tzu-Lung, et al.
Publicado: (2016)

IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
por: Kubota, Hiroaki, et al.
Publicado: (2019)

Evolution of carbapenem resistance in klebsiella pneumoniae and escherichia coli carrying bla(NDM−1) gene: imipenem exposure results in sustained resistance memory of strains in vitro
por: Zhao, Qiong, et al.
Publicado: (2023)

High Prevalence of Ceftazidime-Resistant Klebsiella pneumoniae and Increase of Imipenem-Resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR Program in 2004
por: Lee, Kyungwon, et al.
Publicado: (2006)

Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007
por: Lee, Kyungwon, et al.
Publicado: (2010)

Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China
por: Cienfuegos-Gallet, Astrid V., et al.
Publicado: (2022)

Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea: 2003 KONSAR Surveillance
por: Lee, Kyungwon, et al.
Publicado: (2006)

Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms
por: Lee, Chang-Ro, et al.
Publicado: (2017)

Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae
por: Han, Yu-Ling, et al.
Publicado: (2022)

Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China
por: Wang, Dongliang, et al.
Publicado: (2022)

Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
por: Lee, Kyungwon, et al.
Publicado: (2004)

Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae in China
por: Li, Cuidan, et al.
Publicado: (2022)

Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
por: Weng, Yuesong, et al.
Publicado: (2023)

Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China
por: Yang, Xuemei, et al.
Publicado: (2022)

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
por: Chen, Luke F, et al.
Publicado: (2012)

In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
por: Tang, Hung-Jen, et al.
Publicado: (2015)

Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
por: Bovo, Federica, et al.
Publicado: (2023)

Genetic Diversity of Polymyxin-Resistance Mechanisms in Clinical Isolates of Carbapenem-Resistant Klebsiella pneumoniae: a Multicenter Study in China
por: Li, Ziyao, et al.
Publicado: (2023)

Drug Susceptibility and Molecular Epidemiology of Klebsiella pneumoniae Bloodstream Infection in ICU Patients in Shanghai, China
por: Xiao, Shuzhen, et al.
Publicado: (2021)

High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae
por: Wu, Ping-Feng, et al.
Publicado: (2016)

Corrigendum: Molecular epidemiology and mechanism of Klebsiella pneumoniae resistance to ertapenem but not to other carbapenems in China
por: Wang, Dongliang, et al.
Publicado: (2023)

Antimicrobial resistance and risk factors for mortality of pneumonia caused by Klebsiella pneumoniae among diabetics: a retrospective study conducted in Shanghai, China
por: Liu, Bing, et al.
Publicado: (2019)

Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries
por: Girmenia, Corrado, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ij9ifbvrh2ststov39ka8otqol